CLOSE

Nippon India Nifty Pharma ETF

very highequityindex
23.51 -0.01(-0.05%) NAV as on 05 Dec 2025
2.74 % 1 M
2.66 % 1 Y
21.27 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

0.21

As on 31 Oct, 2025
Age :

4 yrs 5 m

Since 06 07 ,2021
Exit Load :

%

AUM :

1,022.91 Crs

Portfolio Price To Book Value :

6.08

Investing Style :

Large Growth

Min. Investment :

SIP NA & Lumpsum 1000

Category :

etfs

Fund Manager :

Jitendra Tolani

Launch Date :

06-Jul-21

Scheme Benchmark :

NA

FUND OBJECTIVE

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2025
Others 0.02 %
Equity 99.98 %

TOP HOLDINGS

Sun Pharmaceutical Industries...22.18 %
Divi's Laboratories Ltd.10.65 %
Cipla Ltd.10.51 %
Dr. Reddy's Laboratories Ltd.9.08 %
Lupin Ltd.5.91 %

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs99.98

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)13.6512.1619.3221.58
Net Assets(Rs Crores) (as on 31-Mar-2025) 87.63 197.85 643.07 856.43
Scheme Returns(%)(Absolute)-5.25-10.9258.2110.48
B'mark Returns(%)(Absolute)NANANANA
Category Rank109/111150/16029/20139/238

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2025-20264.34-2.37NANA
2024-20253.8418.320.53-9.56
2023-202414.5312.509.1113.01
2022-2023-10.467.10-2.90-4.37
2021-2022NANA-1.68-4.27

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Nifty Pharma ETFVery HighEquity23.51-0.01(-0.05%)NAV As on 05 Dec, 202506-Jul-2021Inception Date1,022.91AUM In Cr.2.66%1Y21.27%3YNA%5Y11.71%Since Inception
DSP Nifty 50 Equal Weight ETFVery HighEquity344.332.04(0.60%)NAV As on 05 Dec, 202508-Nov-2021Inception Date887.64AUM In Cr.9.66%1Y16.76%3YNA%5Y13.91%Since Inception
ICICI Pru Nifty 50 ETFVery HighEquity294.421.72(0.59%)NAV As on 05 Dec, 202520-Mar-2013Inception Date34,935.53AUM In Cr.7.27%1Y13.12%3Y15.89%5Y14.02%Since Inception
Aditya Birla SL Nifty 50 ETFVery HighEquity30.450.18(0.59%)NAV As on 05 Dec, 202521-Jul-2011Inception Date3,189.80AUM In Cr.7.30%1Y13.12%3Y15.89%5Y12.57%Since Inception
Nippon India ETF Nifty 50 BeESVery HighEquity295.941.72(0.59%)NAV As on 05 Dec, 202528-Dec-2001Inception Date53,989.02AUM In Cr.7.26%1Y13.11%3Y15.88%5Y15.72%Since Inception
UTI Nifty 50 ETFVery HighEquity288.031.68(0.59%)NAV As on 05 Dec, 202501-Sep-2015Inception Date69,510.29AUM In Cr.7.27%1Y13.10%3Y15.87%5Y13.85%Since Inception

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd